Intraoperative Electron-Beam Radiation Therapy for Pediatric Ewing Sarcomas and Rhabdomyosarcomas: Long-Term Outcomes
Sole CV(1), Calvo FA(2), Polo A(3), Cambeiro M(4) [SP], Gonzalez C(5), Desco M(6), Martinez-Monge R(4).
(1) Department of Radiation Oncology, Instituto de Radiomedicina, Santiago, Chile; School of Medicine, Complutense University, Madrid, Spain.
(2) School of Medicine, Complutense University, Madrid, Spain; Department of Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
(3) Service of Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
(4) Service of Radiation Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
(5) School of Medicine, Complutense University, Madrid, Spain; Service of Radiation Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
(6) School of Medicine, Complutense University, Madrid, Spain; Department of Experimental Surgery and Medicine, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Magazine: International Journal of Radiation Oncology, Biology, Physics
Date: Aug 1, 2015Radiation Oncology
To assess long-term outcomes and toxicity of intraoperative electron-beam radiation therapy (IOERT) in the management of pediatric patients with Ewing sarcomas (EWS) and rhabdomyosarcomas (RMS).
METHODS AND MATERIALS:
Seventy-one sarcoma (EWS n=37, 52%; RMS n=34, 48%) patients underwent IOERT for primary (n=46, 65%) or locally recurrent sarcomas (n=25, 35%) from May 1983 to November 2012. Local control (LC), overall survival (OS), and disease-free survival were estimated using Kaplan-Meier methods. For survival outcomes, potential associations were assessed in univariate and multivariate analyses using the Cox proportional hazards model.
After a median follow-up of 72 months (range, 4-310 months), 10-year LC, disease-free survival, and OS was 74%, 57%, and 68%, respectively. In multivariate analysis after adjustment for other covariates, disease status (P=.04 and P=.05) and R1 margin status (P<.01 and P=.04) remained significantly associated with LC and OS. Nine patients (13%) reported severe chronic toxicity events (all grade 3).
A multimodal IOERT-containing approach is a well-tolerated component of treatment for pediatric EWS and RMS patients, allowing reduction or substitution of external beam radiation exposure while maintaining high local control rates.
CITATION Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1069-76. doi: 10.1016/j.ijrobp.2015.04.048.
you maybe interested
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.